- Sponsored Content
- Upstream & Downstream Processing
Flow Electroporation for Vaccine Development and Production: From Subunit Vaccines to Ex Vivo Immunotherapy
BPI Contributor
June 1, 2014
1 Min Read
Already have an account?
Sponsored by MaxCyte
MaxCyte flow electroporation is a universal, clinically validated transient transfection platform for rapid, high-quality cell transfection in the development and production of vaccines and cellular immunotherapies.
About the Author
You May Also Like